The Clinical Research On The Therapy Of Traditional Chinese Medicine For Influenza

ObjectiveWe evaluate clinical objectively the clinical effects and medicine safety through the comparison of clinical comprehensive therapeutic effects assessments, the main symptoms score comparison, the comparison of the negative rate of common respiratory viral antigen and The comparison of evalating clinical comprehensive therapeutic effect, which can provide a Chinese Medicine treatment of Influenza.MethodsThe samples of the patients are collected from The Second Affiliate d Hospital of Guangzhou University of Traditional Chinese Medicine in April 2012-July 2015 by Cohort study. The samples are divide into the t reatment group and the control group.Both group is given symptomatic tre atment. The treatment group will be treated dialectically with traditional Chinese medicine while the control group will be treated with Keiwei.Cou rse of the treatment will take 5 days, after which, both would be followed up by call on the 7th day. Observing the comparison of clinical comprehensi ve therapeutic effects assessments、the main symptoms score comparison th e comparison of the negative rate of common respiratory viral antigen, the comparison of evaluating clinical comprehensive therapeutic effect and t he medicine of safety index before and after treatment.Results1. General situation analysis 56 flu patients were collected, who were devided into 2 groups, the treatment with 27 patients, the control group with 29 patients.The gender, age, disease duration, body temperature, medical history, the influenza virus type, syndrome score before treatment between two groups showed no statistical significance (P>0.05)2. Curative effect analysis① The comparison of clinical comprehensive therapeutic effects assessments:the average pyredysis days of the treatment group is 2.33±1.14 days, the control group is 1.96±0.76 days, there i s no statistical signi ficance for the difference of both(P>0.05). Using the uni lateral t test, the treatment group is not inferior to the control group (P＜0.05).②The main symptoms score comparison:The Chinese medicine symptom integral of each group is statistical significance (P＜0.05).Both are no statistical significance at each time point (P＞0.05)③The comparison of the negative rate of common respiratory viral antigen:there is no statistical significance for the difference of both (P ＞0.05).Using the unilateral u test, the treatment group is inferior to the control group (P＞0.05).④The comparison of evaluating clinical comprehensive therapeutic effect:The evaluating clinical comprehensive therapeutic effect of treatment group is 96.3%, while the control group is 77.78%. There is no statistical significance for the difference of both(P＞0.05). Using the unilateral u test, the treatment group is not inferior to the control group (P＜0.05).3. Adverse events There is 7 adverse events occurring during treatment. There is no statistical significance for the difference of both (P>0.05).3 cases were sick at the stomach after taking traditional Chinese medicine decotion. These 3 cases of adverse events were considered and the experimental drug is likely to be relevant.ConclusionThe diagnosing and treating viral pneumonia of this research is from Dr.Zhou, which has achieved a good clinical effects, improve clinical symptoms, cut down the comparison of clinical comprehensive therapeutic effects assessments and curative effect is not bad in KeWei.But There was a slight of gastrointestinal adverse reactions.